Mon, Jul-15-02, 18:22
|
|
Senior Member
Posts: 475
|
|
Plan: Protein Power LP Dilletan
Stats: 164/145/138
BF:
Progress: 73%
|
|
Endocrine Reviews 20 (6): 805-875
Copyright © 1999 by The Endocrine Society
Current and Potential Drugs for Treatment of Obesity
George A. Bray and Frank L. Greenway
c. Amino acids. Administration of 5-hydroxy tryptophan to obese and diabetic subjects (152, 318) will decrease food intake probably by enhancing brain tryptophan, which is converted to serotonin, a neurotransmitter known to reduce food intake. Tryptophan is transported across the blood brain barrier by a transporter that also transports other large neutral amino acids. When these other amino acids are increased, tryptophan entry is reduced by competition for the transporter.
|